Robotic Nanobots in Medicine: Advances, Mechanisms, Applications, and Future Perspectives in Targeted Diagnosis and Therapy

Abstract

Robotic nanobots represent one of the most innovative developments at the intersection of nanotechnology, biomedical engineering, and precision medicine. These nanoscale devices are designed to perform specific biological tasks, including targeted drug delivery, disease diagnosis, molecular sensing, and therapeutic intervention at cellular and subcellular levels. Unlike conventional therapies that distribute drugs throughout the body and may cause systemic adverse effects, robotic nanobots have the potential to transport therapeutic molecules directly to diseased tissues, improving treatment efficiency while reducing toxicity.

Recent advances in nanomaterials, molecular engineering, artificial intelligence, and bio-inspired design have enabled the development of increasingly sophisticated nanorobotic systems. Different propulsion strategies, including magnetic guidance, chemical reactions, ultrasound activation, and biological motors, allow these devices to navigate complex biological environments. In oncology, nanobots have demonstrated promising potential for selective tumor targeting, controlled release of anticancer agents, and early detection of malignant changes. Beyond cancer therapy, emerging applications include antimicrobial treatment, cardiovascular disease management, regenerative medicine, and precision diagnostics.

Despite significant progress, clinical translation of robotic nanobots remains challenging due to limitations related to biocompatibility, immune system interactions, manufacturing complexity, energy supply, navigation accuracy, and long-term safety evaluation. Addressing these barriers requires multidisciplinary collaboration among nanotechnologists, clinicians, engineers, and regulatory authorities. 

This review discusses the fundamental principles, engineering approaches, biomedical applications, current challenges, and future opportunities of robotic nanobots. The integration of nanorobotics with artificial intelligence and personalized medicine may establish a new generation of intelligent therapeutic platforms capable of delivering safer, more precise, and patient-specific healthcare solutions.